Form 4: Molina Healthcare Director Zoretic Receives Equity Grant

Molina Healthcare Director Richard C. Zoretic received a grant of 317 shares of common stock valued at $55,000 as part of his director compensation plan.

Summary

• Richard C. Zoretic, a Director of Molina Healthcare, Inc. (MOH), acquired 317 shares of common stock.
• The transaction occurred on January 1, 2026.
• The shares were granted as part of the Issuer's 2025 Equity Incentive Plan for his services as a Director.
• The aggregate dollar value of this quarterly equity award was $55,000, representing one-quarter of an annual $220,000 award.
• The number of shares was calculated based on the closing price of $173.54 on December 31, 2025, as January 1, 2026, was a non-trading day.
• Following this transaction, Zoretic beneficially owns 7,947 shares indirectly through the Richard Charles Zoretic Revocable Living Trust.

Sentiment

Score: 6

Explanation: The filing reports a routine, pre-scheduled equity grant to a director, which is a neutral to slightly positive event as it aligns director interests with shareholders without indicating any new operational or financial developments.

Positives

• The equity grant aligns the director's interests with those of shareholders, promoting long-term value creation.
• It represents a routine and expected component of director compensation, indicating stable corporate governance practices.

Negatives

• The grant results in a minor increase in outstanding shares, leading to negligible dilution for existing shareholders.

Risks

• No specific company-level risks are disclosed in this Form 4 filing.

Future Outlook

The filing indicates a recurring quarterly equity award structure for directors, suggesting similar grants will occur in subsequent quarters as part of the 2025 Equity Incentive Plan.

Management Comments

• The company's 2025 Equity Incentive Plan provides for an annual equity award to each director valued at $220,000, granted in quarterly installments of $55,000.

Industry Context

This routine director compensation aligns with common practices in the healthcare industry, where equity grants are frequently used to incentivize and retain board members, linking their financial interests to long-term company performance.

Corporate Governance

Stakeholder Impact

• Shareholders: Minor, negligible dilution from the issuance of new shares for compensation, balanced by increased alignment of director interests with long-term company performance.

Next Steps

• Future quarterly equity grants to directors under the 2025 Equity Incentive Plan.

Key Dates

Recommendation

This Form 4 reports a routine, pre-scheduled equity grant to a director as part of their compensation. It does not contain any new material information regarding the company's financial performance, strategic direction, or operational outlook that would warrant a change in investment recommendation. The transaction is an expected part of corporate governance and director incentive structures.

Keywords

Molina Healthcare, MOH, Insider Transaction, Form 4, Equity Grant, Director Compensation, Stock Award, Richard Zoretic